We are live on ! Find out more
MCIM

Meadow Creek Investment Management Portfolio holdings

AUM $5.09B
1-Year Est. Return 5.82%
This Fund
S&P 500
This Quarter Est. Return
+1.57%
1 Year Est. Return
+5.82%
3 Year Est. Return
+54.91%
5 Year Est. Return
10 Year Est. Return
AUM
$5.09B
AUM Growth
+$57.7M
Cap. Flow
+$16.1M
Cap. Flow %
0.32%
Top 10 Hldgs %
24.24%
Holding
1,418
New
67
Increased
484
Reduced
331
Closed
55

Top Buys

Rank Stock Value
1
PS
Pluralsight, Inc. Class A Common Stock
PS
+$17.7M
2
C icon
Citigroup
C
+$14.2M
3
AMZN icon
Amazon
AMZN
+$12.8M
4
JNJ icon
Johnson & Johnson
JNJ
+$11.6M
5
T icon
AT&T
T
+$11.1M

Top Sells

Rank Stock Value
1
CNC icon
Centene
CNC
+$18.4M
2
ALLY icon
Ally Financial
ALLY
+$11.3M
3
RHI icon
Robert Half
RHI
+$9.62M
4
WFC icon
Wells Fargo
WFC
+$7.96M
5
FTNT icon
Fortinet
FTNT
+$7.89M

Sector Composition

Rank Sector Weight
1 Technology 18.48%
2 Financials 14.88%
3 Consumer Discretionary 12.73%
4 Healthcare 12.68%
5 Communication Services 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STSA
1301
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$28K ﹤0.01%
+1,876
New +$29.1K
HRTX icon
1302
Heron Therapeutics
HRTX
$70.9M
$27K ﹤0.01%
1,462
MTSI icon
1303
MACOM Technology Solutions
MTSI
$23.4B
$27K ﹤0.01%
+1,260
New +$24.6K
SRPT icon
1304
Sarepta Therapeutics
SRPT
$1.76B
$27K ﹤0.01%
364
+112
+44% +$13.2K
RETA
1305
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$27K ﹤0.01%
336
AVTR icon
1306
Avantor
AVTR
$9.25B
$25K ﹤0.01%
+1,680
New +$28.5K
KURA icon
1307
Kura Oncology
KURA
$853M
$25K ﹤0.01%
1,652
OFIX icon
1308
Orthofix Medical
OFIX
$420M
$25K ﹤0.01%
+464
New +$23.9K
TFIN icon
1309
Triumph Financial Inc
TFIN
$1.8B
$25K ﹤0.01%
+770
New +$23.2K
GPMT
1310
Granite Point Mortgage Trust
GPMT
$60.2M
$24K ﹤0.01%
1,296
ALTR
1311
DELISTED
Altair Engineering Inc
ALTR
$24K ﹤0.01%
680
MRTX
1312
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$24K ﹤0.01%
308
VRNT
1313
DELISTED
Verint Systems
VRNT
$23K ﹤0.01%
1,068
DNTH icon
1314
Dianthus Therapeutics
DNTH
$6.05B
$22K ﹤0.01%
133
P
1315
Everpure Inc
P
$33B
$22K ﹤0.01%
1,276
-5,676
-82% -$89K
TBPH icon
1316
Theravance Biopharma
TBPH
$875M
$22K ﹤0.01%
1,152
+800
+227% +$16.2K
YMAB
1317
DELISTED
Y-mAbs Therapeutics
YMAB
$22K ﹤0.01%
848
-320
-27% -$8.18K
ENV
1318
DELISTED
ENVESTNET, INC.
ENV
$22K ﹤0.01%
396
CCJ icon
1319
Cameco
CCJ
$42.5B
$21K ﹤0.01%
2,240
QTWO icon
1320
Q2 Holdings
QTWO
$3.92B
$21K ﹤0.01%
264
ICL icon
1321
ICL Group
ICL
$6.96B
$20K ﹤0.01%
4,228
SAP icon
1322
SAP
SAP
$240B
$20K ﹤0.01%
168
-2,156
-93% -$267K
NTNX icon
1323
Nutanix
NTNX
$17.4B
$19K ﹤0.01%
714
QTTB icon
1324
Q32 Bio
QTTB
$468M
$19K ﹤0.01%
+57
New +$19.4K
ACGL icon
1325
Arch Capital
ACGL
$33.3B
$18K ﹤0.01%
420
-13,496
-97% -$532K

Similar funds

Meadow Creek Investment Management's Q3 2019 Portfolio in Review

As of Q3 2019, Meadow Creek Investment Management held 1,418 positions worth $5.09B, up 1.1% from $5.03B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Meadow Creek Investment Management's Q3 2019 filing shows 67 new, 484 increased, 331 reduced and 55 closed positions. Its largest new stake was TSMC: 48,382 shares worth $2.25M. The largest sale was Centene, an estimated $18.4M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Meadow Creek Investment Management's largest Q3 2019 buy was TSMC: 48,382 shares worth $2.25M.
  • Meadow Creek Investment Management added most to Pluralsight, Inc. Class A Common Stock in Q3 2019, an estimated $17.7M increase.
  • Meadow Creek Investment Management's biggest Q3 2019 reduction was Centene, cutting an estimated $18.4M.
  • Meadow Creek Investment Management fully exited Service Properties Trust in Q3 2019, selling an estimated $5.21M.
  • Meadow Creek Investment Management's ten largest holdings make up 24% of its $5.09B portfolio in Q3 2019.
  • Meadow Creek Investment Management opened 67 new positions and closed 55 in Q3 2019.
  • Meadow Creek Investment Management's portfolio value rose 1.1% quarter-over-quarter to $5.09B.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.